<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: A subgroup of patients with an implantable cardioverter defibrillator (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>) experiences <z:hpo ids='HP_0000739'>anxiety</z:hpo> after device implantation </plain></SENT>
<SENT sid="1" pm="."><plain>The purpose of the present study was to evaluate whether <z:hpo ids='HP_0000739'>anxiety</z:hpo> is predictive of <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> and <z:hpo ids='HP_0000001'>all</z:hpo>-cause mortality 1 year post <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> implantation </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: A total of 1012 patients completed the state version of the State-Trait <z:hpo ids='HP_0000739'>Anxiety</z:hpo> Inventory at baseline </plain></SENT>
<SENT sid="3" pm="."><plain>The end points were <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> and mortality the first year after <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> implantation </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Within the first year after <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> implantation, 19% of patients experienced a <z:hpo ids='HP_0004308'>ventricular arrhythmia</z:hpo>, and 4% died </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000739'>Anxiety</z:hpo> was associated with an increased risk of <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> (hazard ratio [HR] = 1.017; 95% confidence interval [CI] = 1.005-1.028; p = .005) and mortality (HR = 1.038; 95% CI = 1.014-1.063; p = .002) in adjusted analysis </plain></SENT>
<SENT sid="6" pm="."><plain>Patients with <z:hpo ids='HP_0000739'>anxiety</z:hpo> (highest tertile) had a 1.9 increased risk for <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> (95% CI = 1.329-2.753; p =.001) and a 2.9 increased risk for mortality (95% CI = 1.269-6.677; p = .01) compared with patients with low <z:hpo ids='HP_0000739'>anxiety</z:hpo> (lowest tertile) </plain></SENT>
<SENT sid="7" pm="."><plain>Among 257 patients with cardiac resynchronization therapy, <z:hpo ids='HP_0000739'>anxiety</z:hpo> was associated with mortality (HR = 5.381; 95% CI = 1.254-23.092; p = .02) after adjusting for demographic and clinical covariates </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: <z:hpo ids='HP_0000739'>Anxiety</z:hpo> was associated with an increased risk of <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> and mortality 1 year after <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> implantation, independent of demographic and clinical covariates </plain></SENT>
<SENT sid="9" pm="."><plain>Monitoring and treatment of <z:hpo ids='HP_0000739'>anxiety</z:hpo> may be warranted in a selected subgroup of high-risk patients with an <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> </plain></SENT>
</text></document>